key: cord-0690042-rbhaemg2 authors: Cao, Austin C.; Nimmo, Zachary M.; Mirza, Natasha; Cohen, Noam A.; Brody, Robert M.; Doty, Richard L. title: Objective screening for olfactory and gustatory dysfunction during the COVID-19 pandemic: a prospective study in healthcare workers using self-administered testing date: 2021-02-12 journal: World J Otorhinolaryngol Head Neck Surg DOI: 10.1016/j.wjorl.2021.02.001 sha: bf04bf754a9c8a16166488852fda64aadfad1f67 doc_id: 690042 cord_uid: rbhaemg2 BACKGROUND: Smell and taste loss are highly prevalent symptoms in coronavirus disease 2019 (COVID-19), although few studies have employed objective measures to quantify these symptoms, especially dysgeusia. Reports of unrecognized anosmia in COVID-19 patients suggests that self-reported measures are insufficient for capturing patients with chemosensory dysfunction. OBJECTIVES: The purpose of this study was to quantify the impact of recent COVID-19 infection on chemosensory function and demonstrate the use of at-home objective smell and taste testing in an at-risk population of healthcare workers. METHODS: Two hundred and fifty healthcare workers were screened for possible loss of smell and taste using online surveys. Self-administered smell and taste tests were mailed to respondents meeting criteria for elevated risk of infection, and one-month follow-up surveys were completed. RESULTS: Among subjects with prior SARS-CoV-2 infection, 73% reported symptoms of olfactory and/or gustatory dysfunction. Self-reported smell and taste loss were both strong predictors of COVID-19 positivity. Subjects with evidence of recent SARS-CoV-2 infection (<45 days) had significantly lower olfactory scores but equivalent gustatory scores compared to other subjects. There was a time-dependent increase in smell scores but not in taste scores among subjects with prior infection and chemosensory symptoms. The overall infection rate was 4.4%, with 2.5% reported by PCR swab. CONCLUSION: Healthcare workers with recent SARS-CoV-2 infection had reduced olfaction and normal gustation on self-administered objective testing compared to those without infection. Rates of infection and chemosensory symptoms in our cohort of healthcare workers reflect those of the general public. Acute olfactory and gustatory dysfunction are highly prevalent symptoms in patients infected 51 with the novel coronavirus disease 2019 . [1] [2] [3] [4] [5] [6] [7] Because early and otherwise 52 asymptomatic transmission plays an important role in viral spread, identifying and characterizing 53 early, isolated symptoms is critical for improving the screening and diagnosis of Many studies have been conducted using subjective reports of acute chemosensory dysfunction, 55 but the results of these studies may be affected by recall bias and sampling issues. Subjective 56 measures are further complicated by the causal relationship between perceived smell and taste 57 loss, as olfaction is a well-established contributor to the sensory experience of "taste." 8 On both the initial screening and end-of-study survey, subjects were asked to indicate whether 117 classified into four groups: 1) "Never Tested" indicating they had never been tested by either 120 J o u r n a l P r e -p r o o f Association of chemosensory 298 dysfunction and COVID-19 in patients presenting with influenza-like symptoms The prevalence of olfactory and 301 gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis Self-reported alteration of sense of smell or taste in 304 patients with COVID-19: a systematic review and meta-analysis on 3563 patients Alterations in smell or taste in mildly symptomatic 307 outpatients with SARS-CoV-2 infection Olfactory and gustatory dysfunctions 309 as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-310 19): a multicenter European study Smell and taste 312 dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin 313 Proc Objective sensory testing methods reveal a 315 higher prevalence of olfactory loss in COVID-19-positive patients compared to subjective 316 methods: a systematic review and meta-analysis The effects of mouth movements, swallowing, and spitting on 318 retronasal odor perception Smell and taste disorders, a study of 750 patients 320 from the University of Pennsylvania Smell and Taste Center 323 Smell dysfunction: a biomarker for COVID-19 Temporary hyposmia in COVID-19 patients. 326 HNO Olfactory and gustatory function impairment in 328 COVID-19 patients: Italian objective multicenter-study Psychophysical tests reveal impaired olfaction 330 but preserved gustation in COVID-19 patients Prevalence and reversibility of smell 333 dysfunction measured psychophysically in a cohort of COVID-19 patients Research electronic data 336 capture (REDCap)--a metadata-driven methodology and workflow process for providing 337 translational research informatics support Development of the 12-item Cross-Cultural Smell 339 Identification Test (CC-SIT) Validation of the Waterless Empirical Taste Test (WETT®) Development of the University of Pennsylvania Smell 343 Identification Test: a standardized microencapsulated test of olfactory function Sensitivity analysis and diagnostic accuracy of the 346 Brief Smell Identification Test in patients with chronic rhinosinusitis Self-Administered Waterless Empirical Taste Test (SA-WETT) Administration 349 Prevalence and duration of acute loss of smell or taste in 351 COVID-19 patients Prevalence and recovery from olfactory and 353 gustatory dysfunctions in Covid-19 infection: a prospective multicenter study Team RC. R: A language and environment for statistical computing Evolution of altered sense of smell or taste in 358 patients with mildly symptomatic COVID-19 Smell and taste recovery in coronavirus disease 361 2019 patients: a 60-day objective and prospective study A pneumonia outbreak associated with a new 364 coronavirus of probable bat origin High expression of ACE2 receptor of 2019-nCoV on the 366 epithelial cells of oral mucosa Dysgeusia in COVID-19: possible 368 mechanisms and implications. Oral Surg Oral Med Oral Pathol Oral Radiol Remote psychophysical evaluation of olfactory 371 and gustatory functions in early-stage coronavirus disease 2019 patients: the Bologna 372 experience of 300 cases Validation of a self-374 administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients 375 in home quarantine Clinical diagnosis and current management strategies for 379 olfactory dysfunction: a review More than smell-COVID-19 is associated with 381 severe impairment of smell, taste, and chemesthesis Sensitivity and specifity of prediction models 383 based on gustatory disorders in diagnosing COVID-19 patients: a case-control study. 384 medRxiv Anosmia in COVID-19: mechanisms and 386 significance Olfactory and rhinological 388 evaluations in SARS-CoV-2 patients complaining of olfactory loss Acute smell and taste loss in outpatients: all infected with 391 SARS-CoV-2? Reasons for healthcare workers becoming infected with novel 393 coronavirus disease 2019 (COVID-19) in China Anosmia as a presenting symptom of 395 SARS-CoV-2 infection in healthcare workers -A systematic review of the literature, case 396 series, and recommendations for clinical assessment and management The epidemiology of olfactory disorders The prevalence of 401 olfactory dysfunction in the general population: a systematic review and meta-analysis COVID-19 symptoms predictive of healthcare workers' 404 SARS-CoV-2 PCR results Sex differences in human olfaction: a meta-406 analysis